AM-643

N/A

Report date: 2022/07/01 15:29:28
NME

Base Information

Drug NameAM-643
Drug Alias NameAM-643
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of Action5-lipoxygenase activating protein inhibitors
Targets5-lipoxygenase activating protein
Therapy Area/IndicationsDermatitis
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesAmira Pharmaceuticals Inc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesAmira Pharmaceuticals Inc
Active IndicationsN/A
Inactive IndicationsDermatitis

Other Information

ATC CodeN/A
Related LinksN/A